Pharma’s attack on drug price negotiations might benefit Biden
Tuesday, February 20th • Segment
Pharmaceutical companies are doing anything they can to stop President Biden’s Medicare program from being able to negotiate prices for their products, including suing the government. Experts say their efforts might actually benefit Biden by reminding voters that he’s taking on big drug companies.
